All News
Filter News
Found 808,674 articles
-
QIAGEN and NeuMoDx expand assay menu for their next generation of fully integrated PCR systems for clinical laboratories in Europe and also announce availability of NeuMoDx 96 version
4/11/2019
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and NeuMoDx Molecular, Inc. today announced an expansion of the content menu for the NeuMoDx™ 96 and 288 Molecular Systems, as well as the commercial availability of the NeuMoDx 96 mid-throughput version of this family of fully integrated PCR-based systems after the initial launch of the NeuMoDx 288 high-throughput version in early 2019.
-
Axcella Presents Late-Breaker Data Demonstrating Lead AXA™ Candidate AXA1665 Impacted Markers Related to Liver Health
4/11/2019
Axcella Health, a biotechnology company pioneering the research and development of novel multifactorial interventions to address dysregulated metabolism and support health, presented new data on the company’s novel endogenous metabolic modulator (EMM) composition, AXA1665, in subjects with mild and moderate hepatic insufficiency or loss of liver function, at The International Liver Congress™ 2019 (EASL).
-
ResMed to Report Third Quarter Fiscal 2019 Earnings on May 2, 2019
4/11/2019
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2019 on Thursday, May 2, 2019, after the New York Stock Exchange closes.
-
Takara Bio submits Drug Master File to US FDA for RetroNectin® GMP grade (liquid format)
4/11/2019
Takara Bio USA, Inc. announced today that its parent company, Takara Bio Inc., submitted a Drug Master File to the Food and Drug Administration for the liquid formulation of RetroNectin GMP grade on March 15, 2019
-
CIVCO Radiotherapy and POLL Medical Announce FDA 510(k) Clearance to Market GrayDuck Tongue-Displacing and Immobilization Oral Stents
4/11/2019
CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric radiotherapy solutions, along with POLL Medical, are excited to announce U.S. Food and Drug Administration (FDA) 510(k) clearance to market GrayDuck Stents™.
-
American Society of Cannabis Medicine Board of Regents Member Dr. Annabelle Manalo Addresses Pharmacy Leaders
4/11/2019
Dr. Annabelle Manalo on Wednesday and Today met over 400 members of the Pharmacy Society of Wisconsin including each of its board members of the Pharmacy Society of Wisconsin.
-
Ophthotech Obtains Exclusive Global License to AAV Gene Therapy Program for BEST1 Related Retinal Diseases
4/11/2019
Ophthotech Corporation (NASDAQ: OPHT) announced today that the Company has converted its option and entered into an exclusive global license agreement with the University of Pennsylvania
-
QIAGEN’s QuantiFERON®-TB Passes Milestone of 60 Million Tests in Global Fight against Tuberculosis, Current Annual Run Rate Exceeds 12 Million Tests
4/11/2019
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its modern gold standard QuantiFERON®-TB test for detection of latent tuberculosis (TB) infections has surpassed 60 million tests administered, having impacted the lives of millions of patients worldwide and supporting the global fight against this public health issue.
-
Wilson Sonsini Goodrich & Rosati Expands Life Sciences Practice
4/11/2019
Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life sciences, and growth enterprises worldwide, announced today that Georgia C. Ravitz and James "Jamie" R. Ravitz have joined the firm's life sciences practice as partners in the Washington, D.C., office
-
Profusa Expands Leadership Team with Digital Health, Government and Business Development Hires
4/11/2019
Profusa, an empowered health company that is pioneering the next generation of personalized medicine, has expanded its leadership team to further the company's ability to transform the health and well-being of patients worldwide.
-
Fe3 Medical Announces Results Of First Human Study Of Transdermal Patch That Uses Electricity To Deliver Iron
4/11/2019
Fe3 Medical, the creators of a transdermal patch for the treatment of iron deficiency anemia, today announced the results from its first human study of the Fe3 proprietary biphasic iontophoretic transdermal technology.
-
Surgical Theater Debuts a New Approach to Patient Engagement Utilizing Augmented Reality with Magic Leap
4/11/2019
Leveraging our rich history of creating dynamic visualization experiences throughout the treatment continuum, Surgical Theater is proud to debut its first ever Augmented Reality that combines Precision VR® patient-specific models with the Magic Leap One spatial computing headset.
-
Abbott and the Abbott Fund Support Relief Efforts for Cyclone Idai
4/11/2019
Abbott (NYSE: ABT) and its foundation, the Abbott Fund, are providing more than $500,000 in grants and healthcare products to support relief efforts for Cyclone Idai in Southeast Africa, including Mozambique, Malawi and Zimbabwe.
-
X4 Pharmaceuticals Announces Proposed Public Offering of Common Stock and Class A Warrants
4/11/2019
X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, announced today that it has commenced an underwritten public offering of shares of its common stock (or pre-funded warrants to purchase common stock in lieu thereof) and Class A warrants to purchase its common stock. All of the securities in the offering will be sold by X4.
-
ALASTIN Skincare®'s TransFORM Body Treatment with TriHex Technology® Accelerates Body Sculpting Results with Unique Peptide and Liposome Delivery System
4/11/2019
ALASTIN Skincare®, Inc. - a specialty aesthetics company dedicated to developing and marketing innovative, clinically-tested physician-dispensed skin care products, is pleased to announce the publication of a clinical study and scientific article highlighting their most recent breakthrough product, TransFORM Body Treatment with TriHex Technology®.
-
New Super-Accurate Optical Atomic Clocks Pass Critical Test
4/11/2019
Researchers have measured an optical clock’s ticking with record-breaking accuracy while also showing the clock can be operated with unprecedented consistency.
-
Corizon Health Broadens Fight against Opioid Addiction
4/11/2019
As the U.S. continues to grapple with solutions to the national opioid addiction epidemic, Brentwood-based Corizon Health is preparing to offer a successful treatment pilot to additional communities the company serves across the U.S.
-
Celularity Enters Lease to Develop Advanced Cell Manufacturing and Research Facility for Commercial-Scale Placental-Derived Allogeneic Cell Therapies
4/11/2019
Celularity, Inc. (“Celularity” or the “Company”), a clinical-stage cell therapeutics company developing allogeneic cellular therapies harnessed from human placentas, today announced the Company has entered into a long-term lease agreement to develop a 145,000 square-foot advanced cell manufacturing and research facility in Florham Park, New Jersey.
-
SomaLogic announces new collaboration with Janssen Research & Development
4/11/2019
Companies to share proteomic and clinical data to drive new drug discovery and development, and precision health management
-
Qualigen Enters into Research Agreement for RAS Inhibitor Cancer Drug with University of Louisville (UofL)
4/11/2019
Qualigen, Inc., and the University of Louisville (UofL) today announced that Qualigen has entered into a Sponsored Research Agreement (SRA) with UofL for development of several small-molecule RAS Inhibitor drug candidates